X4 Pharmaceuticals XFOR
NASDAQ XFOR
$2.87 -0.03 (-1.03%)
As of: Oct 1, 2026 · 10:10 AM EDT

X4 Pharmaceuticals (XFOR) Interest Expenses (2017 - 2026)

Updated

X4 Pharmaceuticals' Interest Expenses came in at $2.16 million for Q2 2026, down 3.0% from $2.23 million a year earlier but up 1.4% from the prior quarter.

Analysis

X4 Pharmaceuticals (XFOR) Interest Expenses (2017 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, X4 Pharmaceuticals reported Interest Expenses of $8.74 million, down 4.5% year-over-year; for FY2025, it was $8.88 million, up 1.2% from FY2024.

  • Interest Expenses has increased in each of the last eight years, with a five-year compound annual growth rate of 27.0% (FY2020 to FY2025).
  • Going back by year, Interest Expenses was $8.77 million in FY2024 (+51.8%), $5.78 million in FY2023 (+44.7%), $3.99 million in FY2022 (+9.6%) and $3.64 million in FY2021 (+35.5%).
  • The five-year range for quarterly Interest Expenses is $913,000 (Q1 2022) to $2.41 million (Q3 2024).
  • Year-over-year, Interest Expenses has declined for four consecutive quarters, with growth averaging 9.0% over the last eight quarters.
  • The fastest year-over-year change in Interest Expenses over five years came in Q2 2024 (growth of 89.5%), and the weakest in Q3 2025 (a decline of 6.5%).
  • Business Quant data shows XFOR's Interest Expenses at $2.13 million (Q1 2026), $2.19 million (Q4 2025) and $2.26 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 X4 Pharmaceuticals 366.40 Mn -332.29 Mn 7.19 Mn 2.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.16 Mn
Mar 31, 2026 2.13 Mn
Dec 31, 2025 2.19 Mn
Sep 30, 2025 2.26 Mn
Jun 30, 2025 2.23 Mn
Mar 31, 2025 2.20 Mn
Dec 31, 2024 2.30 Mn
Sep 30, 2024 2.41 Mn
Jun 30, 2024 2.18 Mn
Mar 31, 2024 1.87 Mn
Dec 31, 2023 1.89 Mn
Sep 30, 2023 1.63 Mn
Jun 30, 2023 1.15 Mn
Mar 31, 2023 1.11 Mn
Dec 31, 2022 1.14 Mn
Sep 30, 2022 1.02 Mn
Jun 30, 2022 918,000.00
Mar 31, 2022 913,000.00
Dec 31, 2021 925,000.00
Sep 30, 2021 920,000.00
API Access

X4 Pharmaceuticals Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=XFOR&period=max&api_key=YOUR_API_KEY